PL1636261T3 - Białka trombopoetynowe o ulepszonych właściwościach - Google Patents
Białka trombopoetynowe o ulepszonych właściwościachInfo
- Publication number
- PL1636261T3 PL1636261T3 PL04740298T PL04740298T PL1636261T3 PL 1636261 T3 PL1636261 T3 PL 1636261T3 PL 04740298 T PL04740298 T PL 04740298T PL 04740298 T PL04740298 T PL 04740298T PL 1636261 T3 PL1636261 T3 PL 1636261T3
- Authority
- PL
- Poland
- Prior art keywords
- tpo
- improved
- thrombopoietin
- proteins
- improved properties
- Prior art date
Links
- 102000036693 Thrombopoietin Human genes 0.000 title abstract 5
- 108010041111 Thrombopoietin Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 101000799461 Homo sapiens Thrombopoietin Proteins 0.000 abstract 2
- 241000282412 Homo Species 0.000 abstract 1
- 101000694103 Homo sapiens Thyroid peroxidase Proteins 0.000 abstract 1
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 abstract 1
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000053400 human TPO Human genes 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03014331 | 2003-06-26 | ||
PCT/EP2004/006887 WO2005000891A2 (en) | 2003-06-26 | 2004-06-25 | Thrombopoietin proteins with improved properties |
EP04740298A EP1636261B1 (en) | 2003-06-26 | 2004-06-25 | Thrombopoietin proteins with improved properties |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1636261T3 true PL1636261T3 (pl) | 2007-12-31 |
Family
ID=33547598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04740298T PL1636261T3 (pl) | 2003-06-26 | 2004-06-25 | Białka trombopoetynowe o ulepszonych właściwościach |
Country Status (9)
Country | Link |
---|---|
US (1) | US7541439B2 (pl) |
EP (1) | EP1636261B1 (pl) |
AT (1) | ATE368687T1 (pl) |
DE (1) | DE602004007924T2 (pl) |
DK (1) | DK1636261T3 (pl) |
ES (1) | ES2289528T3 (pl) |
PL (1) | PL1636261T3 (pl) |
PT (1) | PT1636261E (pl) |
WO (1) | WO2005000891A2 (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007098547A1 (en) * | 2006-03-01 | 2007-09-07 | Apollo Life Sciences Limited | A molecule and chimeric molecules thereof |
GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
WO2008157776A2 (en) * | 2007-06-21 | 2008-12-24 | Angelica Therapeutics, Inc. | Modified diphtheria toxins |
WO2009022154A2 (en) | 2007-08-15 | 2009-02-19 | Circassia Limited | Peptide with multiple epitopes |
EP2268297A4 (en) * | 2008-02-29 | 2011-11-16 | Angelica Therapeutics Inc | MODIFIED TOXINS |
US20110294733A1 (en) * | 2009-01-20 | 2011-12-01 | Hanall Biopharma Co., Ltd. | Modified human thrombopoietin polypeptide fragment and manufacturing method thereof |
CA2863224A1 (en) | 2012-01-09 | 2013-07-18 | The Scripps Research Institute | Ultralong complementarity determining regions and uses thereof |
CN105073781A (zh) | 2013-01-11 | 2015-11-18 | 加州生物医学研究所 | 牛融合抗体 |
JP2016519651A (ja) | 2013-03-15 | 2016-07-07 | アンジェリカ セラピューティックス,インク. | 改質された毒素 |
JP2017518049A (ja) * | 2014-06-06 | 2017-07-06 | ザ カリフォルニア インスティテュート フォー バイオメディカル リサーチ | アミノ末端免疫グロブリン融合タンパク質とその組成物を構築する方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6284471B1 (en) * | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
US6238890B1 (en) * | 1994-02-18 | 2001-05-29 | Washington University | Single chain forms of the glycoprotein hormone quartet |
US5879673A (en) * | 1996-01-25 | 1999-03-09 | Genentech, Inc. | Administration of thrombopoietin on a single day only |
US6458563B1 (en) * | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
HUP0401121A3 (en) * | 2001-02-26 | 2006-01-30 | Merck Patent Gmbh | Modified thrombopoietin with reduced immunogenicity |
BR0214650A (pt) * | 2001-12-04 | 2005-05-03 | Merck Patent Gmbh | Imunocitoquinas com seletividade modulada |
DE60332556D1 (de) * | 2002-05-01 | 2010-06-24 | Danisco Us Inc | Cytokine und cytokinrezeptoren mit reduzierter immunogenität |
-
2004
- 2004-06-25 PL PL04740298T patent/PL1636261T3/pl unknown
- 2004-06-25 PT PT04740298T patent/PT1636261E/pt unknown
- 2004-06-25 AT AT04740298T patent/ATE368687T1/de not_active IP Right Cessation
- 2004-06-25 DK DK04740298T patent/DK1636261T3/da active
- 2004-06-25 DE DE602004007924T patent/DE602004007924T2/de not_active Expired - Fee Related
- 2004-06-25 WO PCT/EP2004/006887 patent/WO2005000891A2/en active IP Right Grant
- 2004-06-25 ES ES04740298T patent/ES2289528T3/es active Active
- 2004-06-25 US US10/561,097 patent/US7541439B2/en not_active Expired - Fee Related
- 2004-06-25 EP EP04740298A patent/EP1636261B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
EP1636261A2 (en) | 2006-03-22 |
ES2289528T3 (es) | 2008-02-01 |
DE602004007924T2 (de) | 2008-04-10 |
EP1636261B1 (en) | 2007-08-01 |
WO2005000891A3 (en) | 2005-04-21 |
ATE368687T1 (de) | 2007-08-15 |
US7541439B2 (en) | 2009-06-02 |
US20060160995A1 (en) | 2006-07-20 |
PT1636261E (pt) | 2007-11-08 |
DE602004007924D1 (de) | 2007-09-13 |
WO2005000891A2 (en) | 2005-01-06 |
DK1636261T3 (da) | 2007-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004011770D1 (de) | Fusionsproteine | |
WO2003099771A3 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
EA200600869A1 (ru) | Антитела, связывающие рецептор интерлейкина-4 | |
DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
WO2004074486A3 (en) | Fusion proteins of interferon alpha muteins with improved properties | |
WO2007091250A8 (en) | Enzyme replacement therapy for treating lysosomal storage diseases | |
BRPI0406605A (pt) | Complexo de proteìna usando um fragmento de imunoglobulina e método para o preparo do mesmo | |
WO2006121610A3 (en) | Personal care compositions and methods for their use | |
PL1636261T3 (pl) | Białka trombopoetynowe o ulepszonych właściwościach | |
DK1687267T3 (da) | Modificeret MscL-proteinkanal | |
EP1544214A4 (en) | Non-neutralizing anti-aPC antibodies | |
TW200724679A (en) | Treatment of disease using an improved regulated expression system | |
WO2004113386A3 (en) | Modified hirudin proteins and t-cell epitopes in hirudin | |
TW200716749A (en) | Interferon-beta gene therapy using an improved, regulated expression system | |
ATE328082T1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
EP1587928A4 (en) | HUMAN SAA3 NUCLEIC ACID MOLECULE, PROTEIN AND METHOD OF USE THEREOF | |
WO2005035564A3 (en) | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders | |
ATE405249T1 (de) | Körpergeruch verändernde biologisch aktive substanzen | |
WO2007134907A3 (en) | Gm-csf gene therapy for treatment of crohn's disease using an improved regulated expression system | |
WO2006110367A3 (en) | Methods and compositions for mycoplasma toxins |